AU2042097A - Treatment for pulmonary fibrosis - Google Patents
Treatment for pulmonary fibrosisInfo
- Publication number
- AU2042097A AU2042097A AU20420/97A AU2042097A AU2042097A AU 2042097 A AU2042097 A AU 2042097A AU 20420/97 A AU20420/97 A AU 20420/97A AU 2042097 A AU2042097 A AU 2042097A AU 2042097 A AU2042097 A AU 2042097A
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- pulmonary fibrosis
- fibrosis
- pulmonary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IL1997/000115 WO1998043642A1 (en) | 1997-03-31 | 1997-03-31 | Treatment for pulmonary fibrosis |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2042097A true AU2042097A (en) | 1998-10-22 |
AU737094B2 AU737094B2 (en) | 2001-08-09 |
Family
ID=11061990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU20420/97A Ceased AU737094B2 (en) | 1997-03-31 | 1997-03-31 | Treatment for pulmonary fibrosis |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0991411A4 (en) |
JP (1) | JP2001518062A (en) |
AU (1) | AU737094B2 (en) |
CA (1) | CA2285350A1 (en) |
WO (1) | WO1998043642A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0944382A1 (en) | 1996-09-30 | 1999-09-29 | Brigham & Women's Hospital | Methods and compounds for treatment of abnormal uterine bleeding |
IL148246A0 (en) * | 1999-09-09 | 2002-09-12 | Hadasit Med Res Service | Promotion of wound healing |
CA2711743C (en) | 2007-01-21 | 2015-04-07 | Agricultural Research Organization | Quinazolinone derivatives for treating or preventing skeletal muscle fibrosis |
AU2013270622B2 (en) * | 2007-01-21 | 2016-05-19 | Agricultural Research Organization | Composition and method for treating or preventing skeletal muscle fibrosis |
US10155742B2 (en) | 2012-01-13 | 2018-12-18 | President And Fellows Of Harvard College | Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions |
WO2019237125A1 (en) | 2018-06-08 | 2019-12-12 | The General Hospital Corporation | Inhibitors of prolyl-trna-synthetase |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2113229C (en) * | 1994-01-11 | 1999-04-20 | Mark Pines | Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof |
US6028075A (en) * | 1997-02-11 | 2000-02-22 | Pines; Mark | Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies |
-
1997
- 1997-03-31 EP EP97908480A patent/EP0991411A4/en not_active Ceased
- 1997-03-31 CA CA002285350A patent/CA2285350A1/en not_active Abandoned
- 1997-03-31 WO PCT/IL1997/000115 patent/WO1998043642A1/en active Application Filing
- 1997-03-31 JP JP52550097A patent/JP2001518062A/en not_active Ceased
- 1997-03-31 AU AU20420/97A patent/AU737094B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP0991411A1 (en) | 2000-04-12 |
EP0991411A4 (en) | 2000-05-31 |
CA2285350A1 (en) | 1998-10-08 |
JP2001518062A (en) | 2001-10-09 |
AU737094B2 (en) | 2001-08-09 |
WO1998043642A1 (en) | 1998-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6537598A (en) | Bronchial stenter | |
AU1814499A (en) | Bronchial stenter | |
AU1093999A (en) | Flavonoids for cystic fibrosis therapy | |
AU5330998A (en) | Avatar kiosk | |
AU2420797A (en) | Novel cystic fibrosis treatment | |
AU1709299A (en) | Mixer-injectors | |
AU6598798A (en) | Resorcinyl-triazines | |
GB9702944D0 (en) | Reducing fibrosis | |
AUPO907397A0 (en) | Game | |
AUPO900097A0 (en) | Process | |
AU9664198A (en) | Method for the treatment of cystic fibrosis | |
AU9551498A (en) | Process | |
AU6998698A (en) | Dioxacycloalkan-8-one | |
AU4117497A (en) | Micropolarimeter | |
AU6185898A (en) | Clavaspirins | |
AU2042097A (en) | Treatment for pulmonary fibrosis | |
AU6764798A (en) | Leukotriene antagonists useful for treating cystic fibrosis | |
AU5192498A (en) | Tissue fibrosis inhibitor | |
AU6525998A (en) | Improved metallo-endopeptidases | |
AU8233098A (en) | Game | |
AU5384298A (en) | Oscillating hauloff | |
AU8860498A (en) | Cleaning method | |
AU1093600A (en) | Stapedial-saccular strut | |
AU2895097A (en) | New thiazolopyridines | |
AU1042899A (en) | Castor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: THE NAME OF THE APPLICANT IN REGARD TO PATENT NUMBER 737094 SHOULD READ: AGRICULTURAL RESEARCH ORGANIZATION, MINISTRY OF AGRICULTURE AND HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT COMPANY LTD. |